Saturday, January 20, 2018

eCOST Action CA15105


eCOST (European Cooperation in Science and Technology) is the longest-running European framework supporting trans-national cooperation among researchers, engineers and scholars across Europe.

European Medicines Shortages Research Network - addressing supply problems to patients (Medicines Shortages) 

The problems created by supply shortages of medicines have been widely reported by healthcare professionals and patients over recent years, and acknowledged at the European level by the European Medicines Agency and European Commission. The cited causes are multifaceted ranging from production disruptions, natural disasters, discontinuations as well as difficulties created by various legal, trade and pricing frameworks. Healthcare professionals require access to reliable and up-to-date information about the unavailability of a medicine in order that they can treat the patient in the best way possible. The significant patient impact because of the lack of medication, in terms of safety and management of their condition, will be researched. In addition the forced substitution to an alternative product or requirement to produce a medicine may increase the risk of error, stress and overall cost to the healthcare system. According to the largest pan-European survey of healthcare professionals yet conducted on the topic, the products mainly affected in the European hospital sector are antimicrobials and oncology products used for large populations. This Action will encourage systematic sharing of information and research about past, ongoing and future shortages of medicines and nutritional products. The Action aims to respond to clinical, financial and quality of life interests, to achieve analytical clarity on disruption causes, to simulate decision making in medicines production and trade, to highlight restrictive legal and economic frameworks, to disclose disincentives in the supply chain such as conflicts of interest or problematic cost-benefit ratios, and to reflect on best coping practices. 

It is a unique means for them to jointly develop their own ideas and new initiatives across all fields in science and technology, including social sciences and humanities, through pan-European networking of nationally funded research activities. Based on a European intergovernmental framework for cooperation in science and technology, COST has been contributing - since its creation in 1971 - to closing the gap between science, policy makers and society throughout Europe and beyond. As a precursor of advanced multidisciplinary research, COST plays a very important role in building a European Research Area (ERA).

It anticipates and complements the activities of the EU Framework Programmes, constituting a “bridge” towards the scientific communities of COST Inclusiveness Target Countries. It also increases the mobility of researchers across Europe and fosters the establishment of scientific excellence.The problems created by supply shortages of medicines have been widely reported by healthcare professionals and patients over recent years, and acknowledged at the European level by the European Medicines Agency and European Commission. The cited causes are multifaceted ranging from production disruptions, natural disasters, discontinuations as well as difficulties created by various legal, trade and pricing frameworks.

Healthcare professionals require access to reliable and up-to-date information about the unavailability of a medicine in order that they can treat the patient in the best way possible. The significant patient impact because of the lack of medication, in terms of safety and management of their condition, will be researched. In addition the forced substitution to an alternative product or requirement to produce a medicine may increase the risk of error, stress and overall cost to the healthcare system. According to the largest pan-European survey of healthcare professionals yet conducted on the topic, the products mainly affected in the European hospital sector are antimicrobials and oncology products used for large populations.


This Action will encourage systematic sharing of information and research about past, ongoing and future shortages of medicines and nutritional products. The Action aims to respond to clinical, financial and quality of life interests, to achieve analytical clarity on disruption causes, to simulate decision making in medicines production and trade, to highlight restrictive legal and economic frameworks, to disclose disincentives in the supply chain such as conflicts of interest or problematic cost-benefit ratios, and to reflect on best coping practices.


Related links




  • COST brochure on ISSU
  • Horizon 2020
  • FET - Future and Emerging Technologies 
  • Why European Research?
  • European Research Area (ERA)
  • Research at the European Commission



  • Sources

    Photos


    Meeting in Brussels, 10-11 Apr 2018



    Meeting in Krakow, 25 Jan 2018

    Meeting in Belgrade, 18 Jan 2018

    Meeting in Valetta, 12-13 Sep 2017

    Meetings & events


    Upcoming meetings and events

    Brussels, BelgiumMC meeting, November 22, 2018

    Brussels, Belgium
    January 2019

    Place tba
    March 2019 (3 days)

    Place tba
    September 2019 (2 days)

    Brussels, Belgium
    January 2020

    Place tba
    March 2020 (3 days)


    Past meetings

    Brussels, Belgium
    10-11 April 2018 (2 days)

    Krakow, Poland
    January 2018

    Belgrade, Serbia
    January 2018

    Brussels, Belgium
    January 2018

    La Valetta, Malta
    September 2017 (2 days)

    Cannes, France
    22nd March 2017

    Brussels, Belgium
    January 2017

    Bucharest, Romania
    September 2016

    Brussels, Belgium
    April 2016








    Management Committee

    MC ChairSystem (BE)
    MC Vice Chair
    Proposer of the Action
    Science officer
    Administrative officer
    Dr Roberto FRONTINI (DE)
    Prof Helena JENZER
    Ms Melae LANGBEIN
    Ms Gabriela CRISTEA

    Working Group Leaders

    WG LeaderProf Isabelle HUYS
    WG LeaderProf Claude FARRUGIA
    WG LeaderMs Jane NICHOLSON
    WG LeaderMr Nenad MILJKOVIC
    WG LeaderDr Tomasz BOCHENEK
    ■ Data registration in e-COST pending subject to online registration and nomination acceptance by nominee.

    COST Participants

    CountryMC Member
    AustriaMs Gunda GITTLER
    AustriaMs Martina JESKE
    BelgiumProf Steven SIMOENS
    BelgiumProf Isabelle HUYS
    Bosnia and HerzegovinaMs Vesna VUJIC-ALEKSIC
    Bosnia and HerzegovinaDr Lana NEZIC
    CroatiaMs Darija KURUC POJE
    CroatiaDr Suzana MIMICA MATANOVIĆ
    CyprusDr Panagiotis PETROU
    CyprusMr Georgios SAVVA
    DenmarkDr Trine KART
    DenmarkDr Marianne Hald CLEMMENSEN
    EstoniaMs Marika SAAR
    FranceMr François HOUŸEZ
    FranceDr Guillaume BÉRAUD
    GermanyDr Roberto FRONTINI
    GermanyMr Jürgen FUNKE
    GreeceDr Leonidas TZIMIS
    GreeceDr Mina GAGA
    HungaryDr Botond LAKATOS
    IrelandMs Joan PEPPARD
    IrelandDr Vincent HARGADEN
    IsraelProf David SCHWARTZ
    IsraelMs Michal DAVIDESCU
    ItalyDr Francesca VENTURINI
    ItalyProf Roy CERQUETI
    LatviaDr Inese SVIESTIŅA
    LatviaMs Baiba ZIEMELE
    LithuaniaDr Aurelija BURINSKIENE
    MaltaProf Claude FARRUGIA
    MaltaProf Lilian M. AZZOPARDI
    MontenegroProf Bogdan ASANIN
    MontenegroProf Natasa DUBORIJA-KOVACEVIC
    NorwayDr Kristian SVENDSEN
    PolandDr Tomasz BOCHENEK
    PortugalProf João MIRANDA
    RomaniaMr Paul ANDREIANU
    RomaniaMr Ioan ANTOFIE
    SerbiaMr Nenad MILJKOVIC
    SerbiaMs Dragana RAJINAC
    SloveniaMr Franci TRATAR
    SpainDr Iñigo DE MIGUEL BERIAIN
    SpainDr Elena ATIENZA-MACIAS
    SwitzerlandProf Stefan GROESSER
    SwitzerlandDr Maurizio BATTISTINI
    United KingdomMs Jane NICHOLSON
    United KingdomMr Philip HOWARD
    CountryMC Substitute
    BelgiumMs Elfi DE WEERDT
    CroatiaProf Iskra Alexandra NOLA
    CroatiaProf Ana BOROVECKI
    GreeceDr Eleni RINAKI
    GreeceMs Despoina MAKRIDAKI
    IrelandProf Sheila RYDER
    IsraelMr Michael KHALEMSKY
    LithuaniaProf Vida DAVIDAVICIENE
    Malta■ Ms Miriam KERR
    Montenegro■ Ms Željka BEŠOVIĆ
    SerbiaMs Jasminka DRAGIC
    SerbiaDr Veselin MITROVIC
    SpainProf Jaime ESPIN BALBINO
    SwitzerlandProf Pascal BONNABRY
    SwitzerlandDr Priska VONBACH
    SwitzerlandDr Enea MARTINELLI
    United KingdomMr David PREECE
    United KingdomMr Nick KAYE

    Source

    Parties

     

    MoU037/15
    CSO Approval date30/10/2015
    Start of Action14/04/2016
    End of Action13/04/2020

    Participations

    CountryDateStatus
    Austria21/06/2016Confirmed
    Belgium31/12/2015Confirmed
    Bosnia and Herzegovina18/02/2016Confirmed
    Croatia01/04/2016Confirmed
    Cyprus28/04/2016Confirmed
    Denmark07/01/2016Confirmed
    Estonia15/05/2018Confirmed
    France27/04/2016Confirmed
    Germany24/11/2015Confirmed
    Greece24/11/2015Confirmed
    Hungary30/12/2016Confirmed
    Ireland04/04/2016Confirmed
    Israel02/02/2016Confirmed
    Italy15/12/2016Confirmed
    Latvia28/04/2016Confirmed
    Lithuania31/03/2017Confirmed
    Malta28/11/2015Confirmed
    Montenegro08/03/2016Confirmed
    Norway22/08/2017Confirmed
    Poland03/03/2016Confirmed
    Portugal26/04/2016Confirmed
    Romania30/05/2016Confirmed
    Serbia08/02/2016Confirmed
    Slovenia15/11/2015Confirmed
    Spain25/02/2016Confirmed
    Switzerland21/01/2016Confirmed
    United Kingdom16/11/2015Confirmed


    Sourse